Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

EW

Edwards Lifesciences Corp

May 06 • 04:00PM ET

83.20

+0.29 0.35 %

Healthcare • Medical Devices • USA • Large • NYSE

Peers: MDT ABT BSX SYK ISRG ZBH TFX COO ALGN

| Held by: VTI VOO VO IVV SPY VTV VOT XLV RSP IHI

Scroll to Statements

Index	S&P 500	P/E	45.20	EPS (ttm)	1.84	Insider Own	1.34%	Shs Outstand	576.54M	Perf Week	2.44%
Market Cap	47.97B	Forward P/E	24.68	EPS next Y	3.37	Insider Trans	-2.51%	Shs Float	568.79M	Perf Month	2.92%
Enterprise Value	46.17B	PEG	1.78	EPS next Q	0.74	Inst Own	101.70%	Short Float	1.64%	Perf Quarter	4.30%
Income	1.08B	P/S	7.61	EPS this Y	17.58%	Inst Trans	0.81%	Short Ratio	1.81	Perf Half Y	0.16%
Sales	6.30B	P/B	4.67	EPS next Y	11.99%	ROA	7.93%	Short Interest	9.33M	Perf YTD	-2.40%
Book/sh	17.80	P/C	19.99	EPS next 5Y	13.90%	ROE	10.43%	52W High	87.89 -5.34%	Perf Year	11.05%
Cash/sh	4.16	P/FCF	35.93	EPS past 3/5Y	-9.46% 6.79%	ROIC	9.76%	52W Low	72.30 15.08%	Perf 3Y	-6.24%
Dividend Est.	-	EV/EBITDA	25.84	Sales past 3/5Y	4.08% 6.70%	Gross Margin	79.89%	Volatility	2.89% 2.70%	Perf 5Y	-9.32%
Dividend TTM	-	EV/Sales	7.32	EPS Y/Y TTM	22.90%	Oper. Margin	27.69%	ATR (14)	2.34	Perf 10Y	136.05%
Dividend Ex-Date	-	Quick Ratio	3.09	Sales Y/Y TTM	13.81%	Profit Margin	17.06%	RSI (14)	54.75	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	3.72	EPS Q/Q	5.52%	SMA20	2.59%	Beta	0.87	Target Price	97.91
Payout	0.00%	Debt/Eq	0.06	Sales Q/Q	16.70%	SMA50	1.18%	Rel Volume	0.98	Prev Close	82.91
Employees	16000	LT Debt/Eq	0.06	Earnings	Apr 23 AMC	SMA200	2.52%	Avg Volume	5.17M	Price	83.20
IPO	Mar 27, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.98% 3.24%	Trades		Volume	5,083,742	Change	0.35%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-01-26	Upgrade	Wolfe Research	Peer Perform → Outperform	$92
Jan-09-26	Upgrade	TD Cowen	Hold → Buy	$97
Dec-18-25	Upgrade	JP Morgan	Neutral → Overweight	$100
Nov-03-25	Upgrade	Raymond James	Mkt Perform → Outperform	$96
Oct-29-25	Upgrade	Wolfe Research	Underperform → Peer Perform
Oct-29-25	Upgrade	Jefferies	Hold → Buy	$98
Oct-08-25	Downgrade	Oppenheimer	Outperform → Perform
Oct-07-25	Upgrade	Evercore ISI	In-line → Outperform	$88
Jul-29-25	Upgrade	BTIG Research	Neutral → Buy	$100
Apr-24-25	Upgrade	Piper Sandler	Neutral → Overweight	$80
Jan-30-25	Upgrade	Stifel	Hold → Buy	$75 → $90
Jan-16-25	Downgrade	Wolfe Research	Peer Perform → Underperform	$60
Dec-16-24	Upgrade	BofA Securities	Neutral → Buy
Oct-11-24	Resumed	Morgan Stanley	Equal-Weight	$70
Sep-18-24	Downgrade	Jefferies	Buy → Hold	$85 → $70
Jul-31-24	Upgrade	Daiwa Securities	Neutral → Outperform
Jul-29-24	Upgrade	Wolfe Research	Underperform → Peer Perform
Jul-25-24	Downgrade	Truist	Buy → Hold	$110 → $82
Jul-25-24	Downgrade	TD Cowen	Buy → Hold	$100 → $70
Jul-25-24	Downgrade	Robert W. Baird	Outperform → Neutral	$102 → $70

Show Previous Ratings

May-05-26 05:36AM	Edwards names Theodora Mistras as CFO (MedTech Dive)
May-04-26 04:45PM	Edwards Lifesciences Announces Appointment of CFO (Business Wire)
May-02-26 11:50AM	Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue (Business Wire)
Apr-28-26 07:05AM	Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference (Business Wire)
Apr-24-26 10:25AM	Edwards Lifesciences raises FY26 guidance following strong Q1 (Medical Device Network) +5.56%
08:34AM	Loading…
08:34AM	Edwards raises 2026 forecast as TAVR sales surge (MedTech Dive)
03:15AM	Edwards Lifesciences Corp (EW) Q1 2026 Earnings Call Highlights: Strong Sales Growth and Raised ... (GuruFocus.com)
Apr-23-26 04:33PM	Heart-Valve Maker Edwards Lifesciences Pops On First-Quarter Beat (Investor's Business Daily)
04:15PM	Edwards Lifesciences Reports First Quarter Results (Business Wire)
Apr-22-26 11:28AM	How ISRG Just Secured The U.S. Market (Trefis)
Apr-16-26 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026 (Business Wire)
Apr-08-26 09:31AM	Tired of AI and Oil? Buy the Robot. (Trefis)
Apr-01-26 11:47PM	A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market (Proactive)
09:46AM	Disney upgraded, Nike downgraded: Wall Street's top analyst calls (The Fly)
Mar-30-26 10:00AM	Two Year Data on Edwards Lifesciences EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits (Business Wire)
06:16AM	Loading…
Mar-27-26 06:16AM	Philips wins FDA clearance for imaging device developed with Edwards (MedTech Dive)
Mar-10-26 09:34AM	5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside (Zacks)
09:05AM	National Vision Gains 129.5% in a Year: What's Driving the Rally? (Zacks)
08:24AM	Should You Continue to Hold DGX Stock in Your Portfolio? (Zacks)
Mar-09-26 01:03PM	IDEXX Laboratories Stock Climbs 39.4% in a Year: What's Driving It? (Zacks)
12:17PM	Is Edwards Lifesciences Stock Outperforming the S&P 500? (Barchart)
Mar-06-26 09:14AM	COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook (Zacks)
Mar-05-26 10:57AM	Clover Health Enters Collaboration to Be Part of CMS Aligned Network (Zacks)
10:56AM	Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now (Zacks)
Mar-04-26 09:20AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Feb-26-26 09:15AM	Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose (Business Wire)
Feb-24-26 08:46AM	Zacks Industry Outlook Highlights Intuitive Surgical, Edwards Lifesciences and Electromed (Zacks)
Feb-23-26 03:45PM	Here is Why Edwards Lifesciences Corporation (EW) Looks Attractive (Insider Monkey)
08:53AM	3 Medical Instrument Stocks Banking on GenAI to Tackle Industry Woes (Zacks)
05:56AM	Loading…
05:56AM	Podcast: Which pharma and medtech companies came out on top in 2025 revenues? (Pharmaceutical Technology)
Feb-19-26 05:11PM	Top Stock Reports for UnitedHealth, Honeywell & Shopify (Zacks)
07:05AM	Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences (Business Wire)
Feb-15-26 06:52AM	Edwards Lifesciences Corporation (EW) Draws Positive Analyst View After Q4 Update (Insider Monkey)
Feb-13-26 06:28PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
07:57AM	BSX Posts Q4 Earnings: Should You Buy, Sell or Hold the Stock? (Zacks)
07:05AM	Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access Day (Business Wire)
Feb-12-26 01:26PM	A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH (MarketBeat)
Feb-11-26 05:02PM	Options Corner: Edwards Lifesciences Poor Start To The New Year Offers A Contrarian Opportunity (Benzinga)
04:07PM	Edwards Wavers Analysts Debate Its Earnings Miss Amid Hefty TAVR Investments (Investor's Business Daily)
11:00AM	Edwards Slips As Analysts Debate Its Earnings Miss Amid Hefty TAVR Investments (Investor's Business Daily)
08:30AM	Edwards Lifesciences Corporation Q4 2025 Earnings Call Summary (Moby)
08:17AM	EW's Q4 Earnings Miss Estimates, Revenues Up Y/Y, Stock Climbs (Zacks)
07:44AM	Edwards reports strong 2025 despite Q4 EPS miss (Medical Device Network)
01:24AM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
12:01AM	Edwards Lifesciences Corp (EW) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst ... (GuruFocus.com)
Feb-10-26 10:07PM	Edwards Lifesciences Q4 Earnings Call Highlights (MarketBeat)
06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics (Zacks)
04:46PM	Edwards Lifesciences Pops On Its Bullish 2026 View Despite Mixed Fourth Quarter (Investor's Business Daily)
04:29PM	Edwards Lifesciences Comes Up Mixed, But Offers A Bullish 2026 View (Investor's Business Daily)
04:15PM	Edwards Lifesciences Reports Fourth Quarter Results (Business Wire)
Feb-09-26 02:08PM	MedTech Stocks to Report Earnings on Feb. 10: DGX, ZBH & EW (Zacks)
09:47AM	What Are Wall Street Analysts' Target Price for Edwards Lifesciences Stock? (Barchart)
Feb-06-26 08:15AM	The TAVR Pioneer Bets Everything on One Market as Its Competitor Spreads Risk (24/7 Wall St.)
Feb-05-26 09:15AM	Ahead of Edwards Lifesciences (EW) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Feb-04-26 10:23AM	Edwards Lifesciences' Q4 Earnings on Deck: Here's What to Expect (Zacks)
Feb-03-26 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026 (Business Wire)
Feb-02-26 09:51PM	Edwards Lifesciences Corporation (EW): A Bull Case Theory (Insider Monkey)
07:05AM	Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference (Business Wire)
Jan-31-26 09:35AM	Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW) (Insider Monkey)
Jan-30-26 02:31PM	Renewed Growth Cycle Drives a Favorable Sentiment Towards Edwards Lifesciences (EW) (Insider Monkey)
Jan-26-26 05:06AM	Intuitives cardiac initiative includes valve repair, LAA closure (MedTech Dive)
Jan-25-26 11:44AM	Beyond Biotech-3 Healthcare Stocks for Growth-Minded Investors (MarketBeat)
Jan-19-26 09:25AM	Does Edwards Lifesciences (EW) Have Strong Double-Digit Earnings Potential? (Insider Monkey)
Jan-15-26 08:42AM	Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy (Benzinga)
Jan-14-26 01:19PM	JPM26: Edwards Lifesciences targets 10% growth in 2026 (Medical Device Network)
07:50AM	Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now? (Zacks)
Jan-13-26 09:01AM	What to Expect From Edwards Lifesciences' Q4 2025 Earnings Report (Barchart)
Jan-12-26 09:31AM	Court Ruling Ends Edwards Lifesciences $1.2 Billion Plan To Acquire JenaValve (Benzinga)
07:38AM	Edwards JenaValve acquisition nixed as FTC injunction approved by court (Medical Device Network)
05:37AM	Edwards calls off JenaValve buyout after court halts deal (MedTech Dive)
Jan-09-26 06:48PM	Edwards Comments on JenaValve Acquisition (Business Wire)
Dec-26-25 12:20PM	EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy (Zacks)
Dec-24-25 12:45PM	HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
08:40AM	How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth? (Zacks)
Dec-23-25 10:21AM	The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences (Zacks)
09:00AM	FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy (Business Wire)
Dec-22-25 11:07AM	4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026 (Zacks)
Dec-18-25 07:05AM	Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-11-25 08:09AM	Should You Continue to Hold EW Stock in Your Portfolio? (Zacks)
Dec-04-25 09:00AM	Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference (Business Wire)
Dec-03-25 12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Dec-02-25 03:57AM	How Is Edwards Lifesciences Stock Performance Compared to Other Medical Device Stocks? (Barchart)
Nov-30-25 03:29PM	HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Nov-24-25 08:25AM	BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now? (Zacks)
Nov-11-25 05:58AM	Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish? (Barchart)
Nov-09-25 04:00PM	Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease (Business Wire)
Nov-07-25 01:23PM	Top Analyst Reports for JPMorgan Chase, Salesforce & Arista Networks (Zacks)
Nov-05-25 01:59PM	Do Options Traders Know Something About Edwards Lifesciences Stock We Don't? (Zacks)
10:27AM	Is the Options Market Predicting a Spike in Edwards Lifesciences Stock? (Zacks)
Oct-31-25 07:35PM	Closing Bell Movers: Amazon soars to all-time highs on earnings (TipRanks)
04:25PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
04:12PM	The 'Halo Effect' Bolstering Edwards Lifesciences' Biggest Moneymaker (Investor's Business Daily)
11:59AM	Edwards CFO Scott Ullem to exit post (MedTech Dive)
10:51AM	Demographic Megatrend: Stocks Poised to Benefit From Global Aging (Zacks)
10:17AM	EW Stock Gains on Q3 Earnings and Revenue Beat, Margins Crash (Zacks)
07:56AM	Edwards boosts FY25 outlook after Q3 surpasses expectations (Medical Device Network)
Oct-30-25 11:05PM	Edwards Lifesciences Corp (EW) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
06:00PM	Edwards Lifesciences (EW) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:24PM	Edwards Jumps On Beat-And-Raise, Announces CFO Transition (Investor's Business Daily)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ullem Scott B.	CVP, Chief Financial Officer	May 05 '26	Option Exercise	59.26	13,000	770,337	52,079	May 05 07:08 PM
Lippis Daniel J.	CVP, TAVR	May 01 '26	Option Exercise	59.26	1,019	60,383	34,953	May 04 07:30 PM
Lippis Daniel J.	CVP, TAVR	May 04 '26	Option Exercise	59.26	1,019	60,383	34,701	May 04 07:30 PM
Lippis Daniel J.	CVP, TAVR	May 04 '26	Sale	83.98	1,019	85,576	33,682	May 04 07:30 PM
Lippis Daniel J.	CVP, TAVR	May 01 '26	Sale	83.01	1,019	84,585	33,934	May 04 07:30 PM
Lippis Daniel J.	Officer	May 04 '26	Proposed Sale	83.98	1,019	85,576		May 04 04:32 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 09 '26	Option Exercise	59.26	13,000	770,337	52,699	Apr 09 07:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 09 '26	Sale	80.04	13,000	1,040,544	39,699	Apr 09 07:34 PM
Lippis Daniel J.	CVP, TAVR	Apr 06 '26	Option Exercise	59.26	1,019	60,383	34,953	Apr 06 08:42 PM
Lippis Daniel J.	CVP, TAVR	Apr 06 '26	Sale	80.98	1,019	82,523	33,934	Apr 06 08:42 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 02 '26	Option Exercise	59.26	22,680	1,343,942	43,946	Apr 02 05:13 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 02 '26	Sale	80.16	22,680	1,818,055	21,266	Apr 02 05:13 PM
Ullem Scott B.	CVP, Chief Financial Officer	Mar 11 '26	Option Exercise	59.26	13,000	770,337	52,699	Mar 11 05:15 PM
Ullem Scott B.	CVP, Chief Financial Officer	Mar 11 '26	Sale	84.92	13,000	1,103,896	39,699	Mar 11 05:15 PM
Lippis Daniel J.	CVP, TAVR	Mar 11 '26	Option Exercise	59.26	1,019	60,383	34,953	Mar 11 05:10 PM
Lippis Daniel J.	CVP, TAVR	Mar 11 '26	Sale	85.38	1,019	87,004	33,934	Mar 11 05:10 PM
Lippis Daniel J.	Officer	Mar 11 '26	Proposed Sale	85.38	3,057	261,013		Mar 11 04:05 PM
Ullem Scott B.	Officer	Mar 11 '26	Proposed Sale	84.92	26,000	2,207,790		Mar 11 04:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 02 '26	Option Exercise	59.26	11,340	671,971	32,606	Mar 02 05:50 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 02 '26	Sale	85.93	11,340	974,430	21,266	Mar 02 05:50 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 25 '26	Sale	83.84	24,000	2,012,076	21,266	Feb 26 07:33 PM
DONALD E BOBO JR.	Officer	Feb 25 '26	Proposed Sale	83.84	24,000	2,012,076		Feb 26 04:08 PM
Zovighian Bernard J	CEO	Feb 12 '26	Option Exercise	59.26	25,350	1,502,157	106,326	Feb 13 05:37 PM
Zovighian Bernard J	CEO	Feb 12 '26	Sale	76.67	22,430	1,719,741	83,896	Feb 13 05:37 PM
Zovighian Bernard J	Officer	Feb 12 '26	Proposed Sale	76.67	22,430	1,719,742		Feb 12 04:54 PM
Lippis Daniel J.	CVP, TAVR	Jan 09 '26	Option Exercise	59.26	1,019	60,383	23,021	Jan 09 05:41 PM
Lippis Daniel J.	CVP, TAVR	Jan 09 '26	Sale	85.70	1,019	87,332	22,002	Jan 09 05:41 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 06 '26	Option Exercise	59.26	11,340	671,971	43,210	Jan 06 06:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 06 '26	Sale	85.66	11,340	971,429	31,870	Jan 06 06:02 PM
BOBO DONALD E JR	Officer	Jan 06 '26	Proposed Sale	85.66	45,360	3,885,715		Jan 06 04:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 12 '25	Sale	83.76	11,386	953,748	38,970	Dec 12 05:57 PM
Lippis Daniel J.	CVP, JAPAC	Dec 12 '25	Option Exercise	59.26	1,019	60,383	23,021	Dec 12 05:57 PM
Lippis Daniel J.	CVP, JAPAC	Dec 12 '25	Sale	84.03	1,019	85,625	22,002	Dec 12 05:57 PM
STONE HEISZ LESLIE	Director	Dec 12 '25	Sale	83.41	2,615	218,120	30,948	Dec 12 05:57 PM
BOBO JR FAMILY TRUST	Officer	Dec 12 '25	Proposed Sale	83.74	5,900	494,066		Dec 12 04:22 PM
STONE HEISZ LESLIE	Director	Dec 12 '25	Proposed Sale	83.41	2,615	218,119		Dec 12 04:04 PM
BOBO DONALD E JR	Officer	Dec 12 '25	Proposed Sale	83.78	5,487	459,682		Dec 12 04:03 PM
Chopra Daveen	CVP, TMTT & Surgical	Dec 11 '25	Sale	84.38	2,000	168,750	32,201	Dec 11 05:58 PM
Chopra Daveen	Officer	Dec 11 '25	Proposed Sale	84.38	2,000	168,750		Dec 11 04:01 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 10 '25	Option Exercise	59.26	11,340	671,971	61,696	Dec 10 06:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 10 '25	Sale	83.83	11,340	950,581	50,356	Dec 10 06:58 PM
Zovighian Bernard J	CEO	Dec 08 '25	Option Exercise	59.26	25,350	1,502,157	106,326	Dec 10 06:58 PM
Zovighian Bernard J	CEO	Dec 08 '25	Sale	85.21	21,487	1,831,006	84,839	Dec 10 06:58 PM
Zovighian Bernard J	CEO	Dec 10 '25	Sale	83.45	3,863	322,367	8,597	Dec 10 06:58 PM
BOBO DONALD E JR	Officer	Dec 10 '25	Proposed Sale	83.83	11,340	950,582		Dec 10 04:38 PM
Zovighian Bernard J	Officer	Dec 10 '25	Proposed Sale	83.45	3,863	322,367		Dec 10 04:37 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '25	Option Exercise	59.26	7,700	456,277	47,598	Dec 09 05:01 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '25	Sale	84.47	7,700	650,412	39,898	Dec 09 05:01 PM
Markowitz Wayne	CVP, JAPAC	Dec 08 '25	Sale	86.01	583	50,144	17,563	Dec 08 05:50 PM
Markowitz Wayne	Officer	Dec 08 '25	Proposed Sale	86.01	583	50,144		Dec 08 04:13 PM
Zovighian Bernard J	Officer	Dec 08 '25	Proposed Sale	85.21	21,487	1,831,006		Dec 08 04:12 PM
Wood Larry L	Former Affiliate	Nov 11 '25	Proposed Sale	85.12	26,850	2,285,355		Nov 12 01:30 PM
Ullem Scott B.	CVP, Chief Financial Officer	Nov 10 '25	Option Exercise	59.26	13,000	770,337	52,898	Nov 10 06:07 PM
Ullem Scott B.	CVP, Chief Financial Officer	Nov 10 '25	Sale	83.08	13,000	1,080,093	39,898	Nov 10 06:07 PM
Lippis Daniel J.	CVP, JAPAC	Nov 10 '25	Option Exercise	59.26	1,020	60,442	23,022	Nov 10 06:06 PM
Lippis Daniel J.	CVP, JAPAC	Nov 10 '25	Sale	82.55	1,020	84,196	22,002	Nov 10 06:06 PM
Lippis Daniel J.	Officer	Nov 10 '25	Proposed Sale	82.55	3,058	252,423		Nov 10 04:08 PM
Ullem Scott B.	Officer	Nov 10 '25	Proposed Sale	83.08	20,700	1,719,841		Nov 10 04:07 PM
Wood Larry L	Former Affiliate	Oct 16 '25	Proposed Sale	73.02	8,950	653,522		Oct 16 04:07 PM
Chopra Daveen	CVP, TMTT	Aug 25 '25	Sale	81.95	2,500	204,865	30,996	Aug 25 06:25 PM
Chopra Daveen	Officer	Aug 25 '25	Proposed Sale	81.95	2,500	204,865		Aug 25 04:15 PM
Wood Larry L	Global President TAVR & Surg	Aug 18 '25	Option Exercise	59.26	8,950	530,347	215,850	Aug 18 06:11 PM
Wood Larry L	Global President TAVR & Surg	Aug 18 '25	Sale	78.06	8,950	698,679	206,900	Aug 18 06:11 PM
Wood Larry L	Officer	Aug 18 '25	Proposed Sale	78.06	8,950	698,679		Aug 18 04:29 PM
Lippis Daniel J.	CVP, JAPAC	Jul 28 '25	Sale	79.46	4,114	326,900	22,002	Jul 28 06:23 PM
Lippis Daniel J.	Officer	Jul 28 '25	Proposed Sale	79.46	4,114	326,900		Jul 28 04:04 PM
Wood Larry L	Global President TAVR & Surg	Jun 16 '25	Option Exercise	59.26	8,950	530,347	215,850	Jun 16 05:09 PM
Wood Larry L	Global President TAVR & Surg	Jun 16 '25	Sale	75.23	8,950	673,268	206,900	Jun 16 05:09 PM
Wood Larry L	Officer	Jun 16 '25	Proposed Sale	75.23	8,950	673,268		Jun 16 04:20 PM
Zovighian Bernard J	CEO	May 30 '25	Sale	77.21	16,099	1,243,065	9,564	Jun 03 05:15 PM
Zovighian Bernard J	CEO	Jun 03 '25	Sale	77.32	967	74,772	8,597	Jun 03 05:15 PM
Zovighian Bernard J	Officer	Jun 03 '25	Proposed Sale	77.32	967	74,772		Jun 03 04:29 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jun 02 '25	Sale	77.40	2,570	198,911	50,356	Jun 02 05:01 PM
BOBO DONALD E JR	Officer	Jun 02 '25	Proposed Sale	77.40	2,570	198,911		Jun 02 04:03 PM
Zovighian Bernard J	Officer	May 30 '25	Proposed Sale	77.21	16,099	1,243,064		May 30 04:31 PM
Chopra Daveen	CVP, TMTT	May 22 '25	Sale	75.08	1,500	112,612	33,496	May 22 05:08 PM
Chopra Daveen	Officer	May 22 '25	Proposed Sale	75.07	1,500	112,612		May 22 04:01 PM
Lippis Daniel J.	CVP, JAPAC	May 09 '25	Option Exercise	45.28	330	14,941	26,946	May 09 07:35 PM
Lippis Daniel J.	CVP, JAPAC	May 09 '25	Sale	74.42	330	24,560	26,616	May 09 07:35 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 09 '25	Option Exercise	45.28	11,250	509,363	52,348	May 09 07:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 09 '25	Sale	74.40	11,250	837,035	41,098	May 09 07:34 PM
Lippis Daniel J.	Officer	May 09 '25	Proposed Sale	74.42	330	24,560		May 09 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EW

Edwards Lifesciences Corp

Upgrade your Finviz experience